Trials / Completed
CompletedNCT02336360
Augmenting Flortaucipir Dosimetry Estimates
A Multicenter Study to Obtain Data to Assist in Radiation Dosimetry Calculations From Subjects Enrolled in Human Studies Employing 18F-AV-1451
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flortaucipir F18 | No flortaucipir administered in this study. Subjects received flortaucipir in an Avid-sponsored study. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2015-01-13
- Last updated
- 2020-08-11
- Results posted
- 2020-08-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02336360. Inclusion in this directory is not an endorsement.